Noveltreat 1 mg Pre-filled Pen is a once-weekly injectable medication designed to support weight management in adults with Obesity or those who are overweight with weight-related health conditions such as cardiovascular disease. Each box contains 2 pre-filled pens for convenient administration. Sun Pharmaceuticals manufactures Noveltreat 1 mg pen in GMP-compliant facilities.
This medicine contains FDA-approved Semaglutide base (1 mg/0.5 ml), a Glucagon-like Peptide-1 (GLP-1) receptor agonist that mimics natural hormones in the body. Semaglutide slows gastric emptying and controls appetite, which leads to decreased calorie intake and gradual weight loss. It helps regulate blood sugar levels by leading to insulin release when glucose levels are elevated.
The starting dose of Semaglutide is 0.25 mg once weekly for the first four weeks, gradually increasing to 1 mg weekly as the body adjusts to the medication. The injection should be administered under the skin in the thigh, abdomen, or upper arm on the same day each week. Treatment effectiveness is enhanced when combined with a reduced-calorie diet and increased physical activity.
Common side effects of Noveltreat 1 mg include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, which typically diminish as your body adapts to the medication. Before starting Noveltreat, inform the doctor about any history of Pancreatitis, thyroid disorders, or kidney problems.
Store Noveltreat 1 mg Pre-filled Pen in the refrigerator between 2°C-8°C before first use. After initial use, it can be stored at room temperature below 30°C or refrigerated for up to 6 weeks. Keep the pen cap on when not in use to protect from light, and dispose of used pens properly in a sharps container.
Noveltreat 1 mg Pre-filled Pen offers significant benefits for people struggling with weight management and metabolic health. Some of them include:
Noveltreat 1 mg Pre-filled Pen is a prescription medicine that should be used under medical supervision. Follow these guidelines for proper administration:
Noveltreat Pre-filled Pen is currently available in a single strength at Cheap Medicine Shop. However, the following effective alternatives are available:
| Wegovy 0.5 mg | $270.58/injection |
| Wegovy 0.25 mg | $270.58/injection |
| Wegovy 1 mg | $270.58/injection |
Like any medication, Noveltreat 1 mg Pre-filled Pen can cause side effects that are mostly mild and temporary as the body adjusts. Some of them include:
If any of these effects persist or worsen, seek medical help immediately.
Liver Disease
Patients with liver disease should use Noveltreat 1 mg with caution. Also, inform the healthcare provider about any liver conditions. Regular monitoring may be recommended for those with significant liver dysfunction.
Kidney Impairment
Noveltreat should be used with caution in the case of kidney impairment, particularly in those with severe renal disease. While dose adjustment may not be necessary for mild to moderate kidney dysfunction, gastrointestinal side effects like nausea can lead to dehydration, potentially worsening kidney function. Regular monitoring and adequate hydration are essential during treatment.
Pregnant and Breastfeeding women
Semaglutide injection is not recommended during pregnancy, as it can harm the developing fetus. Discontinue the medication at least 2 months before a planned pregnancy. It is unknown whether Semaglutide passes into breast milk, so breastfeeding women should consult a healthcare provider to weigh potential risks and benefits before use.
Avoid
Do not use Noveltreat in case of a history of Medullary Thyroid Carcinoma (cancer of the thyroid gland) or Multiple Endocrine Neoplasia Syndrome Type 2 (tumor of the endocrine gland) and Type 1 Diabetes. Avoid this medication if allergic to Semaglutide. Avoid alcohol use as it can increase the possibility of low blood sugar and worsen gastrointestinal side effects.
Yes, Noveltreat can be used alongside other Diabetes medications, such as Metformin or SGLT2 inhibitors. However, when combined with insulin or sulfonylureas, your doctor may need to adjust doses to prevent Hypoglycaemia (low blood sugar). Always inform the healthcare professional about all medications you're taking to ensure safe treatment.
Most people begin noticing weight loss within 4-8 weeks of treatment, with more significant results appearing after 3-6 months of consistent use. The gradual dose escalation allows your body to adjust while maximizing effectiveness. Combining Noveltreat with dietary changes and regular exercise enhances results and supports long-term weight management.
People with a history of Medullary Thyroid Cancer, Multiple Endocrine Neoplasia Syndrome Type 2, or those who've had severe allergic reactions to Semaglutide should not use Noveltreat. It's also not suitable for individuals with Type 1 Diabetes, or pregnant and breastfeeding women.
If you miss your weekly dose and remember within 5 days, take it immediately and continue your regular schedule. If more than 5 days have passed, leave the missed injection dose entirely and take your next injection on the regularly scheduled day. Never double-dose to compensate for a missed injection.
You can take Noveltreat at any time of day that's convenient for you, with or without food. However, choose the same day each week and try to inject around the same time for the best results.
No, Noveltreat is not safe during pregnancy and should be discontinued at least 2 months before trying to conceive. Animal studies have depicted potential risks to fetal development, and weight loss during pregnancy provides no benefit while potentially causing harm.
No, discontinuing Noveltreat often leads to weight gain as the appetite-suppressing effects wear off. Never stop the medication abruptly without medical guidance, and discuss sustainable strategies with your doctor for maintaining your weight loss achievements.